Objectives The primary objective of this study is to compare freedom from biochemical
failure (FFBF) between stereotactic body radiation therapy (SBRT) and intensity-modulated …

Background: Patients with a high pretreatment IPSS may have higher rates of late urinary
morbidity after radiation therapy for prostate cancer. Stereotactic body radiation therapy …

Purpose: To report an update of our previous experience using stereotactic body radiation
therapy (SBRT) for the primary treatment of prostate cancer, risk stratified by the updated …

Purpose/Objective (s): The current study reports long-term overall survival (OS) and
biochemical freedom from recurrence (BFFR) after stereotactic body radiation therapy …

Abstract Background Stereotactic Body Radiotherapy (SBRT) has excellent control rates for
low-and intermediate-risk prostate carcinoma. The role of SBRT for high-risk disease …

Background Ultrahypofractionation using stereotactic body radiotherapy (SBRT) is an
increasingly utilized technique for men with prostate cancer (PC). The comparative efficacy …

Purpose No direct comparisons between extreme hypofractionation and conventional
fractionation have been reported in randomized trials for the treatment of localized prostate …

Background This dose-escalation study evaluated the toxicity and efficacy of different
stereotactic body radiation therapy (SBRT) doses for selecting an optimal dose for prostatic …

Purpose Stereotactic body radiation therapy (SBRT) is a technically demanding prostate
cancer treatment that may be less expensive than intensity-modulated radiation therapy …

Purpose To assess the toxicity profile of prostate cancer stereotactic body radiation therapy
(SBRT) in 3 fractions. Methods and Materials This was a prospective, multicenter phase 2 …